Education
About Us
Working with TipRanks
Follow Us
Day One Biopharmaceuticals (DAWN)
NASDAQ:DAWN
DAWN Analyst Ratings
Hold
1 Buy
8 Hold
0 Sell
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
DAWN Stock 12 Month Forecast
Average Price Target
$20.86
▼(-2.11% Downside)
| Highest Price Target$21.50 | Average Price Target$20.86 | Lowest Price Target$17.00 |
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.
Detailed List of Analyst Forecasts
Detailed List of Analyst Forecasts
H.C. Wainwright
$22→$21.5
Hold
0.89%
Upside
Downgraded
03/10/26
J.P. Morgan
$21.5
Hold
0.89%
Upside
Downgraded
03/10/26
Wedbush
$30→$21.5
Hold
0.89%
Upside
Downgraded
03/09/26
Needham
―
Hold
―
Downgraded
03/06/26
Piper Sandler
$25→$21.5
Hold
0.89%
Upside
Downgraded
03/06/26
TD Cowen
$24→$21.5
Hold
0.89%
Upside
Downgraded
03/06/26
JonesTrading
$20→$21.5
Hold
0.89%
Upside
Downgraded
03/06/26
Bank of America Securities
$17
Buy
-20.23%
Downside
Reiterated
03/05/26
Oppenheimer
―
Hold
―
Reiterated
02/26/26
Goldman Sachs
$18
Buy
-15.53%
Downside
Reiterated
07/15/25
Analyst Type
Any
Ranks
Any
Analyst Rating
Any
Upside/ Downside
Any
Action
Any
H.C. Wainwright
$22→$21.5
Hold
0.89%
Upside
Downgraded
03/10/26
J.P. Morgan
$21.5
Hold
0.89%
Upside
Downgraded
03/10/26
Wedbush
$30→$21.5
Hold
0.89%
Upside
Downgraded
03/09/26
Needham
―
Hold
―
Downgraded
03/06/26
Piper Sandler
$25→$21.5
Hold
0.89%
Upside
Downgraded
03/06/26
TD Cowen
$24→$21.5
Hold
0.89%
Upside
Downgraded
03/06/26
JonesTrading
$20→$21.5
Hold
0.89%
Upside
Downgraded
03/06/26
Bank of America Securities
$17
Buy
-20.23%
Downside
Reiterated
03/05/26
Oppenheimer
―
Hold
―
Reiterated
02/26/26
Goldman Sachs
$18
Buy
-15.53%
Downside
Reiterated
07/15/25
Best Analysts Covering Day One Biopharmaceuticals
3 Months
xxx
Success Rate
10/20 ratings generated profit
Average Return
+14.85%
reiterated a xxx
rating 12 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 50.00% of your transactions generating a profit, with an average return of +14.85% per trade.
1 Year
Success Rate
13/20 ratings generated profit
Average Return
+68.05%
reiterated a buy rating 12 days ago
Copying Alec Stranahan's trades and holding each position for 1 Year would result in 65.00% of your transactions generating a profit, with an average return of +68.05% per trade.
2 Years
xxx
Success Rate
16/20 ratings generated profit
Average Return
+86.02%
reiterated a xxx
rating 12 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 80.00% of your transactions generating a profit, with an average return of +86.02% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.
DAWN Analyst Recommendation Trends
Rating
Nov 25
Dec 25
Jan 26
Feb 26
Mar 26
Strong Buy
17
16
22
16
16
Buy
1
1
9
10
17
Hold
2
3
16
19
38
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
20
20
47
45
71
Each month's total comprises the sum of three months' worth of ratings.
DAWN Financial Forecast
DAWN Stock Forecast FAQ
What is DAWN’s average 12-month price target, according to analysts?
Based on analyst ratings, Day One Biopharmaceuticals’s 12-month average price target is 20.86.
What is DAWN’s upside potential, based on the analysts’ average price target?
Currently there's no upside potential for DAWN, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is DAWN a Buy, Sell or Hold?
Day One Biopharmaceuticals has a consensus rating of Hold which is based on 1 buy ratings, 8 hold ratings and 0 sell ratings.
What is Day One Biopharmaceuticals’s price target?
The average price target for Day One Biopharmaceuticals is 20.86. This is based on 9 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $21.50 ,the lowest forecast is $17.00. The average price target represents -2.11% Decrease from the current price of $21.31.
The highest analyst price target is $21.50 ,the lowest forecast is $17.00. The average price target represents -2.11% Decrease from the current price of $21.31.
What do analysts say about Day One Biopharmaceuticals?
Day One Biopharmaceuticals’s analyst rating consensus is a Hold. This is based on the ratings of 9 Wall Streets Analysts.
How can I buy shares of DAWN?
Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.